Product
10x106 ASC
1 clinical trial
1 indication
Indication
OsteoarthritisClinical trial
A Phase IIb, Prospective, Multicentre, Double-blind, Triple-arm, Randomized Versus Placebo Trial, to Assess the Efficacy of a Single Injection of Either 2 or 10 x 106 Autologous Adipose Derived Mesenchymal Stromal Cells (ASC) in the Treatment of Mild to Moderate Osteoarthritis (OA) of the Knee, Active and Unresponsive to Conservative Therapy for at Least 12 MonthsStatus: Active (not recruiting), Estimated PCD: 2022-09-01